These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23217380)

  • 21. Microspot immunoassay-based analysis of plasma protein profiles for biomarker discovery strategies.
    Sonntag J; Mannsperger H; Jöcker A; Korf U
    Methods Mol Biol; 2011; 785():237-45. PubMed ID: 21901604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy.
    Manson JE
    Metabolism; 2013 Jan; 62 Suppl 1():S15-9. PubMed ID: 23018143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo study: response to Kramer et al.
    Oda E; Kawai R
    Diabetes Care; 2009 Oct; 32(10):e125; author reply e126. PubMed ID: 19793999
    [No Abstract]   [Full Text] [Related]  

  • 24. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
    Herder C; Karakas M; Koenig W
    Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus. Results from the D.E.S.I.R. prospective cohort.
    Alessi MC; Nicaud V; Scroyen I; Lange C; Saut N; Fumeron F; Marre M; Lantieri O; Fontaine-Bisson B; Juhan-Vague I; Balkau B; Tregouet DA; Morange PE;
    Thromb Haemost; 2011 Sep; 106(3):416-22. PubMed ID: 21800006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A 81-year-old case of latent autoimmune diabetes mellitus in adult].
    Wang TQ; Liu YS; Qu GY; Xiao X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):369. PubMed ID: 16136990
    [No Abstract]   [Full Text] [Related]  

  • 27. [Individualized medicine - our (lack of) understanding].
    Windeler J
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):5-10. PubMed ID: 22325102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [IFG].
    Tominaga M
    Nihon Rinsho; 2006 Sep; Suppl 3():11--5. PubMed ID: 17022492
    [No Abstract]   [Full Text] [Related]  

  • 29. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
    Baudhuin LM; Donato LJ; Uphoff TS
    Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of nanobiotechnology in the development of personalized medicine.
    Jain KK
    Med Princ Pract; 2011; 20(1):1-3. PubMed ID: 21160206
    [No Abstract]   [Full Text] [Related]  

  • 31. Association of polymorphisms within the transforming growth factor-β1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations.
    Valladares-Salgado A; Angeles-Martínez J; Rosas M; García-Mena J; Utrera-Barillas D; Gómez-Díaz R; Escobedo-de la Peña J; Parra EJ; Cruz M
    Nephrology (Carlton); 2010 Sep; 15(6):644-8. PubMed ID: 20883286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meeting the technical challenges of personalized medicine and companion diagnostics.
    Montagna RA
    MLO Med Lab Obs; 2012 Jan; 44(1):16, 18, 20 passim. PubMed ID: 22352180
    [No Abstract]   [Full Text] [Related]  

  • 33. Urine metabolomics combined with the personalized diagnosis guided by Chinese medicine reveals subtypes of pre-diabetes.
    Wei H; Pasman W; Rubingh C; Wopereis S; Tienstra M; Schroen J; Wang M; Verheij E; van der Greef J
    Mol Biosyst; 2012 Apr; 8(5):1482-91. PubMed ID: 22414982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell surface membrane proteins as personalized biomarkers: where we stand and where we are headed.
    Várady G; Cserepes J; Németh A; Szabó E; Sarkadi B
    Biomark Med; 2013 Oct; 7(5):803-19. PubMed ID: 24044572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Personalized therapy for diabetes mellitus: the path from disease to the patient].
    Dedov II; Shestakova MV
    Ter Arkh; 2014; 86(10):4-9. PubMed ID: 25509884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translational bioinformatics and systems biology approaches for personalized medicine.
    Yan Q
    Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics in evaluation of glucose disorders.
    Sébédio JL; Pujos-Guillot E; Ferrara M
    Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):412-8. PubMed ID: 19474720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical application of non-genetic biomarkers for differential diagnosis of monogenic diabetes.
    Owen KR; Skupien J; Malecki MT;
    Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S15-21. PubMed ID: 20115926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetics of type 2 diabetes and potential clinical implications.
    Kwak SH; Park KS
    Arch Pharm Res; 2013 Feb; 36(2):167-77. PubMed ID: 23377708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.